Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
DiaMedica Therapeutics Inc
DMAC
Healthcare
Biotechnology
DiaMedica Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company is focused on improving the lives of people suffering from serious diseases with a focus on acute ischemic stroke. Its lead candidate DM199 (rinvecalinase alfa) is the first pharmaceutically active recombinant (synthetic) form of the human tissue kallikrein-1 (KLK1) protein to be clinically studied in...
patients. KLK1 is an established therapeutic modality in Asia, with human urinary KLK1, for the treatment of acute ischemic stroke and cardio renal disease, including hypertension. It has also produced a potential novel treatment for severe inflammatory diseases, DM300, which is in the early preclinical stage of development. KLK1 is a serine protease, or protein, produced primarily in the kidneys, pancreas and salivary glands. KLK1 plays a critical role in the regulation of local blood flow and vasodilation in the body, as well as an important role in reducing inflammation and oxidative stress.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:DMAC)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(65)
•••
StockscoutX
X
View Profile
View Bullboard History
Post by
StockscoutX
on Feb 03, 2021 11:31am
Here is something to think about to diversify.
Aristotle - 10 Cancers - One Sample of Blood Unlimited Possibilities. It's on the Toronto Stock Exchange in Canada. QR is about to be released soon as the deployment of Aristotle. The ticker
...more
(0)
•••
TradeSaver2
X
View Profile
View Bullboard History
Post by
TradeSaver2
on Nov 10, 2020 1:43pm
C'mon Jinxmom
you spinless loser...enjoy your cr@p life...end it....we are having fun!
TAG Oil Announces Successful Production Test Results from BED4-T100 Horizontal Well
posted May 17, 2024 9:00am by
TAG Oil Ltd.
-
|
"We are pleased with the performance of our first well in the ARF resource play despite encountering drilling challenges resulting in a shorter lateral section of 308 meters. Looking ahead, TAG Oil plans to drill horizontal wells with lateral lengths of up to 1,000 meters, accompanied by three times ...read more
(65)
•••
StockscoutX
X
View Profile
View Bullboard History
Post by
StockscoutX
on Sep 15, 2020 7:06pm
DiaMedica Therapeutics to Present at Conference
DiaMedica Therapeutics to Present at Lake Street’s Virtual 4th Annual (BIG4) Conference September 17, 2020 Link
(65)
•••
StockscoutX
X
View Profile
View Bullboard History
Post by
StockscoutX
on Sep 15, 2020 7:03pm
DiaMedica Announces First Patients Dosed
DiaMedica Announces First Patients Dosed in Diabetic Kidney Disease Cohort in Phase II REDUX CKD Clinical Study Link
(0)
•••
Carlsoncrew
X
View Profile
View Bullboard History
Post by
Carlsoncrew
on Jun 19, 2020 12:18pm
over 100
Haha jinxmom - you are a loser. go off yourself.
(2)
•••
Pugsrock2
X
View Profile
View Bullboard History
Post by
Pugsrock2
on May 13, 2020 7:25pm
Poaitive Results
Tomorrow should be good
(2)
•••
Pugsrock2
X
View Profile
View Bullboard History
Post by
Pugsrock2
on Feb 27, 2020 6:34pm
Pounded
Hammered in the last few trading sessions
(0)
•••
Jinkmom
X
View Profile
View Bullboard History
Post by
Jinkmom
on Feb 23, 2020 8:54pm
Wondering
Will this company ever reach 100M market cap. Been a decade.
(9)
•••
Roadster2
X
View Profile
View Bullboard History
Post by
Roadster2
on Feb 23, 2020 6:20pm
Another Stroke Drug with PHASE III
A pivotal moment’: Canadian-developed drug shows dramatic outcomes in reducing damage caused by strokes. February 20, 2020, The Globe and Mail A Canadian-developed drug has shown dramatic outcomes in
...more
(2)
•••
Pugsrock2
X
View Profile
View Bullboard History
Comment by
Pugsrock2
on Jan 28, 2020 7:41pm
RE:Huh
I would be nervous too. Go short
(0)
•••
MNdude20
X
View Profile
View Bullboard History
Post by
MNdude20
on Jan 28, 2020 3:39pm
Huh
If the Chief scientific officer quits from a public company why wouldn't that be written in a press release? Conference call good enough? sorry not sure how this works. Nervous about my
...more
(9)
•••
Roadster2
X
View Profile
View Bullboard History
Post by
Roadster2
on Jan 03, 2020 7:45am
New $ 50 million shelf registration filed
Will they sell entire $ 50 million? At what price?
(96)
•••
RockLobster1
X
View Profile
View Bullboard History
Post by
RockLobster1
on Dec 17, 2019 8:40pm
First Patient Dosed in REDUX Phase II Clinical Trial
DiaMedica Therapeutics Announces First Patient Dosed in REDUX Phase II Clinical Trial of DM199 for the Treatment of Chronic Kidney Disease Business Wire
...more
(1)
•••
TrueNorth911
X
View Profile
View Bullboard History
Comment by
TrueNorth911
on Dec 11, 2019 12:50pm
RE:Check on Reality of the Situation--Another reverse split?
Honestly.... I need to thank you. Your my BUY signal. Everytime you pop up on this board, you give me all the info I need to BUY more. Thanks!
(1)
•••
TrueNorth911
X
View Profile
View Bullboard History
Comment by
TrueNorth911
on Dec 11, 2019 12:21pm
RE:Check on Reality of the Situation--Another reverse split?
Was wondering where you've been buttercup. Same ole story over and over... Your copy and paste buttons must be worn off by now. Keep dreaming that we'll give our shares away so that you can
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
GameSquare Announces Formation of FaZe Media, Backed by $11M Investment
Xcyte Digital Corp. Releases "Xperience" Subscription Service
Drilling Approval Received for New Mexico Lithium Project